SIBIONICS

September 03, 2026 – Melbourne -- SIBIONICS showcased its AI-driven continuous glucose monitoring (CGM) sensor, GS3, at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress in Melbourne, held August 18-21 and featuring a company booth, a scientific symposium and on-site interviews with certified diabetes educators (CDEs).

GS3 sensor delivers 14-day monitoring with a 2.9mm profile

The factory-calibrated GS3 sensor is designed for continuous glucose tracking over a 14-day cycle while minimizing physical discomfort through its slim 2.9mm profile. SIBIONICS positioned the device as an extension of its work in brain-computer interfaces, including a retinal prosthesis for patients with retinitis pigmentosa, adapting high-precision biosensor and signal-processing engineering into a more accessible CGM platform.

September 03, 2026 – Melbourne -- SIBIONICS showcased its AI-driven continuous glucose monitoring (CGM) sensor, GS3, at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress held in Melbourne from August 18 to 21, using a dedicated booth, a scientific symposium and on-site interviews with credentialed diabetes educators (CDEs).

Melbourne, Australia -- September 01, 2026 -- SIBIONICS presented its GS3 continuous glucose monitor at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress, held in Melbourne from August 18 to 21, 2026. The company used Booth #1, a scientific symposium and on-site interviews with credentialled diabetes educators to demonstrate the sensor's AI-linked meal-logging and glucose-trend features. GS3 is a factory-calibrated, 14-day continuous glucose monitor with a 2.9 mm on-body profile.